Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline

Article Types

remove_circle_outline

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = intraosseous hibernoma

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
17 pages, 5018 KB  
Systematic Review
Clinical, Radiological, and Pathological Features of Intraosseous Hibernoma: A Systematic Review of Case Reports and Case Series
by Jawad Albashri, Ahmed Albashri, Muhannad Alhamrani, Abdulrahman Hassan, Hisham Shamah, Rayan Alhefzi, Najim Z. Alshahrani, Mohammed R. Algethami, Louis-Romée Le Nail and Ramy Samargandi
Curr. Oncol. 2025, 32(10), 535; https://doi.org/10.3390/curroncol32100535 - 24 Sep 2025
Viewed by 15
Abstract
Intraosseous hibernoma (IOH) is a rare benign tumor composed of brown adipose tissue within the bone, frequently mimicking metastatic lesions and leading to diagnostic challenges. This systematic review aimed to consolidate and analyze all published IOH cases to improve recognition and inform management. [...] Read more.
Intraosseous hibernoma (IOH) is a rare benign tumor composed of brown adipose tissue within the bone, frequently mimicking metastatic lesions and leading to diagnostic challenges. This systematic review aimed to consolidate and analyze all published IOH cases to improve recognition and inform management. A comprehensive literature search was conducted in PubMed, Web of Science, Scopus, Google Scholar, and the Cochrane Library from database inception to March 2025. Studies were eligible for inclusion if they reported histopathologically confirmed cases of intraosseous hibernoma (IOH) in human patients. A total of 62 cases from 30 studies were included. The mean age was 59.2 years, with a female predominance. Lesions were most frequently located in the pelvis and spine and were typically identified incidentally during cancer staging or imaging performed for unrelated indications. Imaging often revealed sclerotic patterns on computed tomography (CT), hyperintense signals on magnetic resonance imaging (MRI) T2-weighted and short tau inversion recovery (STIR) sequences, and mild to moderate uptake on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT). Immunohistochemistry consistently showed S100 protein positivity. Most patients underwent biopsy and were managed conservatively, with no cases of malignant transformation reported. IOH is a benign entity with distinctive radiologic and immunohistochemical features that may mimic malignancy. Awareness of its presentation can reduce misdiagnosis and unnecessary interventions, supporting biopsy-based confirmation and conservative management in most cases. Full article
Show Figures

Figure 1

Back to TopTop